App-Quantinova.ai

Improvement of Gastrointestinal Symptoms After Gluten-Free Diet in Patients With Irritable Bowel Syndrome Is Dependent on the Presence of Anti-Gliadin Antibodies

Andrea Nardelli - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Irritable Bowel Syndrome

N/A

Inpatient Status, Severe Clostridium difficile Infection and Immunocompromised State Predict Failure Despite Multiple Fecal Microbiota Transplants: A Multicenter Study

Colleen R. Kelly - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Clostridium difficile infection

N/A

A Caenorhabditis elegans Model to Study Mechanisms of Microbiota Mediated Protection Against Clostridium difficile

Amtul Moeez - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ulcerative colitis

Dex-HEMA

A Human Gut Ecosystem Protects Against C. difficile Disease and Decreases Inflammation By Targeting C. difficile Toxin tcdA

Shu-Mei He - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Systemic inflammation

N/A

Correlating Quantitative Fecal Immunochemical Test (FIT) Results With Neoplastic Findings on Colonoscopy in a Population-Based Colorectal Cancer Screening Program: A Prospective Study

Laura Gentile - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal Cancer

N/A

Reliability of Endoscopic Ultrasound Indices of Inflammation in Ulcerative Colitis

Mahmoud Mosli - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory bowel disease

N/A

A Comparison of Fecal Immunochemical Testing to Guaiac-Based Fecal Occult Blood Testing in a Colon Cancer Screening Program

Barbara Moysey - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal Cancer

N/A

Reducing Income-Related Inequities in Colorectal Cancer Screening: Lessons Learned From a Retrospective Analysis of Organized Program and Non-Program Screening Delivery in Winnipeg, Manitoba

Alain Demers - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal Cancer

N/A

Evaluation of Colonic Fecal Volume Scoring Systems for Computerized Tomography and their Relationship to Patient- Bowel Habits

David Ferguson - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Inflammatory bowel disease

N/A

Accuracy and Inter-Observer Agreement for Characterization of Colonic Polyps Using the New Optical Enhancement -iSCAN ClosefocusTM Colonoscope

Miriam Fort Gasia - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

P001

Clinical Trial Recruitment With Social Media - What to Expect

Hal Gunn - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

Maternal Antibiotic Use Antepartum or Peripartum Period Is Not Associated With the Development of IBD in offspring: A Population Based Analysis

Charles Burchill - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

Safety, Efficacy, and Pharmacokinetics of Golimumab in Patients with Moderately to Severely Active Ulcerative Colitis: PURSUIT-SC Long term Extension

Peter R. Gibson - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Gallbladder cancer

golimumab

Risk Factors for Serious Infections in Elderly Patients Receiving Infliximab and Other Crohns Disease Therapies: TR-Registry Data

- Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

Infliximab

End of Life Health Care Costs and Utilization in Inflammatory Bowel Disease: A Population-Based Study From Ontario, Canada

Paul D. James - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory bowel disease

N/A

Delayed Response to Golimumab Therapy: UC Patient Characteristics and Long-term Clinical Outcome: Post-Hoc Analyses From the PURSUIT Program

Walter Reinisch - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ulcerative colitis

golimumab

The Prevalence of Cytomegalovirus in Ulcerative Colitis By Disease State and Tissue Based Diagnostic Test: A Systematic Review and Meta-Analysis

Erin Cordeiro - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ulcerative colitis

N/A

Variation in the Treatment of New Onset Pediatric IBD Among Phenotypically Similar Patient Subgroups in Canada: A Cross-Sectional Analysis of the Canadian Children IBD Network Inception Cohort

David R. Mack - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Ulcerative colitis

Methotrexate

Immunosuppressive Medications and Risk of Cytomegalovirus in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

Siddharth Singh - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Inflammatory bowel disease

N/A

Parental Occupations Associated With Social Mixing Are Associated With Risk for Crohn's Disease in Children. A Hypothesis-Generating Epidemiological Study

Rituanjali Kumar - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Crohn's disease

N/A

Filters

28841 Abstracts